Sacituzumab govitecan,Eribulin,Capecitabine,Gemcitabine,Vinorelbine
Everest Medicines,Gilead,roche
[]
ascent trial presented by - deep and durable responses with limited follow-up. 4 deaths on study - 3 infection related. 3 biochemical progressions. 3 pts elected to stop treatment early. no qol. will this be a cure for some? i think we need more time to know. #ash22 
Asst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://t.co/mPeWg1QRrW